Description: The Oncology Institute of Hope and Innovation (TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of more than 1.5 million patients including clinical trials, stem cell transplants, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 80+ employed clinicians and more than 600 teammates in 50 clinic locations and growing, TOI is changing oncology for the better.
Home Page: theoncologyinstitute.com
TOI Technical Analysis
18000 Studebaker Road
Cerritos,
CA
90703
United States
Phone:
213 760 1328
Officers
| Name | Title |
|---|---|
| Mr. Richard Alan Barasch | Exec. Chairman |
| Mr. Bradford D. Hively | CEO & Director |
| Dr. Daniel Virnich FACHE, M.B.A., M.D., MBA | Pres |
| Ms. Hilda Agajanian M.B.A. | Founder & Chief Growth Officer |
| Dr. Richy Agajanian M.D. | Founder & Chief Clinical Officer |
| Mr. Mihir Arunkumar Shah CPA | Chief Financial Officer |
| Dr. Matthew Miller M.B.A., M.D. | Chief Operating Officer |
| Mr. Rakesh Singh M.B.A. | Director of Technology |
| Mr. G. Philip Reger | Chief Information Officer |
| Mr. Mark Hueppelsheuser Esq. | Gen. Counsel |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 46.6667 |
| Price-to-Book MRQ: | 0.6164 |
| Price-to-Sales TTM: | 0.2858 |
| IPO Date: | 2021-11-15 |
| Fiscal Year End: | December |
| Full Time Employees: | 658 |